Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Gazprom Neft approved dividends for 2023

6/28/24 SIBN

Congo offered Lukoil new projects

6/28/24 LKOH

Etalon Group commissioned Domino Premium Residential Complex

6/28/24 ETLN

Pyatyorochka started work in the Jewish Autonomous Region

6/28/24 X5

Lenta will open mini-darkstores in 45 hypermarkets

6/28/24 LENT

VTB reported lower profits in May

6/28/24 VTBR

Shareholders of INARCTICA approved dividends for 3 months 2024

6/28/24 AQUA

Shareholders of INARCTICA approved dividends for 2023

6/28/24 AQUA

Shareholders of Saratov oil refinery plant approved dividends for 2023

6/28/24 KRKN

MD Medical Group acquired RGS-Med clinic

6/28/24 MDMG